Quizartinib (AC220)

10mM in DMSO

  • Product Code: 228383
  CAS:    950769-58-1
Molecular Weight: 560.67 g./mol Molecular Formula: C₂₉H₃₂N₆O₄S
EC Number: MDL Number:
Melting Point: Boiling Point:
Density: Storage Condition: -20°C
Product Description: Used primarily in the treatment of acute myeloid leukemia (AML), especially in patients with FLT3 internal tandem duplication (ITD) mutations. It functions as a selective and potent inhibitor of the FLT3 receptor tyrosine kinase, helping to suppress the growth of leukemic cells. Quizartinib has shown efficacy in reducing tumor burden and prolonging survival in relapsed or refractory AML cases. It is often used in combination with standard chemotherapy or as a bridge to hematopoietic stem cell transplantation. Clinical development focuses on improving outcomes for high-risk AML subgroups with targeted therapy.
Sizes / Availability / Pricing:
Size Availability Price Quantity
1ml 10-20 days €216.09
+
-
Quizartinib (AC220)
Used primarily in the treatment of acute myeloid leukemia (AML), especially in patients with FLT3 internal tandem duplication (ITD) mutations. It functions as a selective and potent inhibitor of the FLT3 receptor tyrosine kinase, helping to suppress the growth of leukemic cells. Quizartinib has shown efficacy in reducing tumor burden and prolonging survival in relapsed or refractory AML cases. It is often used in combination with standard chemotherapy or as a bridge to hematopoietic stem cell transplantation. Clinical development focuses on improving outcomes for high-risk AML subgroups with targeted therapy.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...

Cart

No products

Subtotal: €0.00
€0.00 Total :

The availability date depends on real-time stock, and any changes after payment will be notified within 30 minutes
You can choose the delivery date on the next page